Company: ITMSF
Filing Date: 2025-09-16
Form Type: F-10
Source: 0001493152-25-013556
Chunk: 18

Company: INTERMAP TECHNOLOGIES CORP
Filing Date: 2025-09-16
Form: F-10
Chunk 18
---
 usage. Intermap’s patented, low latency IRIS technology, combined with NEXTMap, is being utilized to turn space imagery into useful geospatial intelligence by enabling orbital space infrastructure, including for orthorectification and altimetry-based accuracy validation.

In addition, Intermap will consider deploying proceeds from any offerings to fund acquisitions that would increase growth and accelerate the achievement of its strategic objectives. Process and technology automation will be key drivers in creating value at target companies with labor-intensive workflows.

For additional information in respect of the business and operations of Intermap, please refer to the headings “ Corporate Structure,” “ General Development of the Business” and “ Description of the Business” in the AIF and the heading “ Business Overview” in the Annual MD&A and updated in the Interim MD&A, all of which are incorporated by reference in this Prospectus.

<div align='center'>CONSOLIDATED CAPITALIZATION</div>

There have been no material changes in the share and loan capital of the Corporation on a consolidated basis since June 30, 2025.

<div align='center'>PRIOR SALES</div>

The prior sales of each class and series of securities that will be distributed under this Prospectus will be disclosed in each applicable Prospectus Supplement.

<div align='center'>TRADING PRICE AND VOLUME</div>

Trading price and volume of the Corporation’s securities will be provided as required for all of our listed securities, as applicable, in each Prospectus Supplement to this Prospectus.

<div align='center'>EARNINGS COVERAGE RATIO</div>

Information regarding earnings coverage ratios will be provided in the applicable Prospectus Supplement relating to any offering of Debt Securities having a term to maturity in excess of one year or Preferred Shares, as required by applicable securities laws.

<div align='center'>USE OF PROCEEDS</div>

The use of proceeds from the sale of Securities will be described in the applicable Prospectus Supplement relating to a specific offering and sale of Securities. Unless otherwise specified in the applicable Prospectus Supplement, Intermap currently intends to use the net proceeds from the sale of Securities to expand and develop the Corporation’s offerings, pursue new strategic contracts and for general corporate purposes. Intermap has no specific, actionable, identified acquisition targets or research projects outside the normal course of business.All capital expenditures are discretionary.

| 7 |

In financial years prior to 2024, the Corporation had a number of years of negative operating cash flow, as disclosed in the Corporation’s financial statements. Although the Corporation intends to use the net proceeds